Original Research

Published on 05 Jun 2023

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease

in Drugs Outcomes Research and Policies

Xiao Zou
Liang Wang
Sha-Sha Sun
Yi-Xin Hu
Hong-Wei Liu
Hao Wang
Jian Cao
Hong-Bin Liu
Li Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183839

1,486 views

Original Research

Published on 02 Jun 2023

Influencing factors of medication literacy among community-dwelling older adult patients with hypertension: a study based on social learning theory

in Drugs Outcomes Research and Policies

Tingting Lu
Zhen Yang
Ping Chen
Jingyan Li
Chen Zheng
Linghui Kong
Huijun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184701

3,050 views
1 citation

Original Research

Published on 01 Jun 2023

Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia

in Drugs Outcomes Research and Policies

Nasser M. Alorfi
Roaya S. Alqurashi
Alanood S. Algarni

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209318

5,148 views
5 citations

Original Research

Published on 01 Jun 2023

Research on named entity recognition of adverse drug reactions based on NLP and deep learning

in Drugs Outcomes Research and Policies

Jianxiang Wei
Tianling Hu
Jimin Dai
Ziren Wang
Pu Han
Weidong Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1121796

2,527 views
4 citations

Clinical Trial

Published on 30 May 2023

Determination of the 95% effective dose of remimazolam tosylate in anesthesia induction inhibits endotracheal intubation response in senile patients

in Drugs Outcomes Research and Policies

Liangchao Qu
Mei Liu
Ru Ouyang
Tianyuan Li
Dingde Long
Yao Jiang
Chengyu Wang
Liqin Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1136003

2,394 views
3 citations

Original Research

Published on 30 May 2023

Does China’s centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model

in Drugs Outcomes Research and Policies

Yang Gu
Qian Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192423

6,036 views
6 citations

Original Research

Published on 24 May 2023

A randomized controlled trial to evaluate the impact of pharmacist-led clinical interventions on the health-related quality of life among TB patients

in Drugs Outcomes Research and Policies

Farman Ullah Khan
Faiz Ullah Khan
Muhammad Tahir Aqeel
Khezar Hayat
Jie Chang
Asim ur Rehman
Yu Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1171985

3,515 views
2 citations

Original Research

Published on 22 May 2023

Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations

in Drugs Outcomes Research and Policies

Yifei Liu
Mark E. Patterson
Suman Sahil
Steven C. Stoner

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1140969

2,460 views
1 citation

Original Research

Published on 22 May 2023

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders

in Drugs Outcomes Research and Policies

Saad S. Alkhowaiter
Amani H. Alshahrani
Hala F. Almarzouqi
Gadah K. Alonazi
Tariq M. Alhawassi
Maha M. AlRasheed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1131354

3,613 views

Original Research

Published on 22 May 2023

Comparation of differences in the performance of corporate social responsibility between Chinese and American pharmaceutical enterprises—based on corporate social responsibility report

in Drugs Outcomes Research and Policies

HongHao Xu
Meng Zhang
ShuZhen Chu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1116466

2,301 views

Original Research

Published on 17 May 2023

Medication use in Italian nursing homes: preliminary results from the national monitoring system

in Drugs Outcomes Research and Policies

S. Zito
E. Poluzzi
A. Pierantozzi
G. Onder
R. Da Cas
I. Ippoliti
C. Lunghi
A. Cangini
F. Trotta

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128605

2,376 views
3 citations

Editorial

Published on 16 May 2023

Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

in Drugs Outcomes Research and Policies

François R. Girardin
Karen Cohen
Matthias Schwenkglenks
Isabelle Durand-Zaleski

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210002

1,983 views
3 citations

Original Research

Published on 15 May 2023

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy

in Drugs Outcomes Research and Policies

Jia-Jia Huang
Zhi-Ye Zou
Zhi-Peng Zhou
Yan Liu
Zhen-Jia Yang
Jing-Jing Zhang
Ying-Yi Luan
Yong-Ming Yao
Ming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1173893

3,650 views
7 citations

Brief Research Report

Published on 12 May 2023

Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19

in Drugs Outcomes Research and Policies

Jiayue Lu
Hong Cai
Yujun Hao
Zhang Lin
Shang Liu
Yaping Zhan
Li Ding
Meilan Huang
Zhenyuan Li
Lan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1161897

3,571 views
3 citations

Systematic Review

Published on 11 May 2023

Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis

in Drugs Outcomes Research and Policies

Wenqin Xiao
Mengting Chen
Ben Wang
Yingxue Huang
Zhixiang Zhao
Zhili Deng
Hongfu Xie
Ji Li
Yan Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169916

10,655 views
6 citations

Original Research

Published on 09 May 2023

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry

in Drugs Outcomes Research and Policies

Mercy Owusu-Asante
Delese Mimi Darko
Stuart Walker
Sam Salek

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184108

1,975 views

Navigation group

Articles

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease

Influencing factors of medication literacy among community-dwelling older adult patients with hypertension: a study based on social learning theory

Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia

Research on named entity recognition of adverse drug reactions based on NLP and deep learning

Determination of the 95% effective dose of remimazolam tosylate in anesthesia induction inhibits endotracheal intubation response in senile patients

Does China’s centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model

A randomized controlled trial to evaluate the impact of pharmacist-led clinical interventions on the health-related quality of life among TB patients

Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders

Comparation of differences in the performance of corporate social responsibility between Chinese and American pharmaceutical enterprises—based on corporate social responsibility report

Medication use in Italian nursing homes: preliminary results from the national monitoring system

Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy

Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19

Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry